Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.

Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S.

J Virol. 2018 May 29;92(12). pii: e02230-17. doi: 10.1128/JVI.02230-17. Print 2018 Jun 15.

PMID:
29593043
2.

Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference.

Chartrand K, Lebel MÈ, Tarrab E, Savard P, Leclerc D, Lamarre A.

Front Immunol. 2018 Jan 4;8:1885. doi: 10.3389/fimmu.2017.01885. eCollection 2017.

3.

Recombinant Vaccinia virus-coded interferon inhibitor B18R: Expression, refolding and a use in a mammalian expression system with a RNA-vector.

Kim YG, Baltabekova AZ, Zhiyenbay EE, Aksambayeva AS, Shagyrova ZS, Khannanov R, Ramanculov EM, Shustov AV.

PLoS One. 2017 Dec 7;12(12):e0189308. doi: 10.1371/journal.pone.0189308. eCollection 2017.

4.

The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Iwata S, Mikami Y, Sun HW, Brooks SR, Jankovic D, Hirahara K, Onodera A, Shih HY, Kawabe T, Jiang K, Nakayama T, Sher A, O'Shea JJ, Davis FP, Kanno Y.

Immunity. 2017 Jun 20;46(6):983-991.e4. doi: 10.1016/j.immuni.2017.05.005. Epub 2017 Jun 13.

PMID:
28623086
5.

Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.

Lapierre P, Janelle V, Langlois MP, Tarrab E, Charpentier T, Lamarre A.

Cell Mol Gastroenterol Hepatol. 2015 Feb 24;1(3):325-341.e1. doi: 10.1016/j.jcmgh.2015.02.002. eCollection 2015 May.

6.

Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.

Zhang LK, Xin QL, Zhu SL, Wan WW, Wang W, Xiao G.

J Virol. 2016 Oct 28;90(22):10259-10270. Print 2016 Nov 15.

7.

Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response.

Becares M, Pascual-Iglesias A, Nogales A, Sola I, Enjuanes L, Zuñiga S.

J Virol. 2016 May 12;90(11):5399-5414. doi: 10.1128/JVI.03259-15. Print 2016 Jun 1.

8.

Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.

Meyer B, Ly H.

J Virol. 2016 Mar 28;90(8):3810-3818. doi: 10.1128/JVI.03049-15. Print 2016 Apr. Review.

9.

Immune Surveillance of the CNS following Infection and Injury.

Russo MV, McGavern DB.

Trends Immunol. 2015 Oct;36(10):637-650. doi: 10.1016/j.it.2015.08.002. Review.

10.

Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity.

McAfee MS, Huynh TP, Johnson JL, Jacobs BL, Blattman JN.

Virology. 2015 Oct;484:153-62. doi: 10.1016/j.virol.2015.05.021. Epub 2015 Jun 20.

11.

Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis.

Shao J, Liang Y, Ly H.

Pathogens. 2015 May 21;4(2):283-306. doi: 10.3390/pathogens4020283. Review.

12.

Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.

Huang C, Kolokoltsova OA, Yun NE, Seregin AV, Ronca S, Koma T, Paessler S.

J Virol. 2015 Jul;89(14):7079-88. doi: 10.1128/JVI.00526-15. Epub 2015 Apr 29.

13.
14.

Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.

Pythoud C, Rothenberger S, Martínez-Sobrido L, de la Torre JC, Kunz S.

J Virol. 2015 Jun;89(12):6240-50. doi: 10.1128/JVI.00610-15. Epub 2015 Apr 1.

15.

New insights into type I interferon and the immunopathogenesis of persistent viral infections.

Snell LM, Brooks DG.

Curr Opin Immunol. 2015 Jun;34:91-8. doi: 10.1016/j.coi.2015.03.002. Epub 2015 Mar 13. Review.

16.

Early virus-host interactions dictate the course of a persistent infection.

Sullivan BM, Teijaro JR, de la Torre JC, Oldstone MB.

PLoS Pathog. 2015 Jan 8;11(1):e1004588. doi: 10.1371/journal.ppat.1004588. eCollection 2015 Jan.

17.

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses.

Russier M, Reynard S, Carnec X, Baize S.

J Virol. 2014 Dec;88(23):13811-20. doi: 10.1128/JVI.01908-14. Epub 2014 Sep 24.

18.

Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Baccala R, Welch MJ, Gonzalez-Quintial R, Walsh KB, Teijaro JR, Nguyen A, Ng CT, Sullivan BM, Zarpellon A, Ruggeri ZM, de la Torre JC, Theofilopoulos AN, Oldstone MB.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8925-30. doi: 10.1073/pnas.1408148111. Epub 2014 Jun 2.

19.

IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Li W, Hofer MJ, Jung SR, Lim SL, Campbell IL.

J Virol. 2014 Jul;88(13):7578-88. doi: 10.1128/JVI.03117-13. Epub 2014 Apr 23.

20.

Differential contributions of tacaribe arenavirus nucleoprotein N-terminal and C-terminal residues to nucleocapsid functional activity.

D'Antuono A, Loureiro ME, Foscaldi S, Marino-Buslje C, Lopez N.

J Virol. 2014 Jun;88(11):6492-505. doi: 10.1128/JVI.00321-14. Epub 2014 Apr 2.

Supplemental Content

Support Center